Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK)
R Morant, J Bernhard, R Maibach, et al.
World Journal of Surgery
|
January 6, 2019
Global Disparities in Breast Cancer Genetics Testing, Counselling and Management
C H Yip, D G Evans, G Agarwal, et al.
British Journal of Cancer
|
April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial
R Morant, J Bernhard, D Dietrich, et al.
British Journal of Cancer
|
March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
E Van Cutsem, L Dirix, J-L Van Laethem, et al.
British Journal of Cancer
|
July 17, 1999
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
N Thatcher, E S De Campos, D R Bell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2002
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study
R Morant, S-F Hsu Schmitz, J Bernhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2000
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
A D Roth, R Maibach, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2015
Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial
N Fazio, R Biffi, R Maibach, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK)
R Morant, J Bernhard, R Maibach, et al.
World Journal of Surgery
|
January 6, 2019
Global Disparities in Breast Cancer Genetics Testing, Counselling and Management
C H Yip, D G Evans, G Agarwal, et al.
British Journal of Cancer
|
April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial
R Morant, J Bernhard, D Dietrich, et al.
British Journal of Cancer
|
March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
E Van Cutsem, L Dirix, J-L Van Laethem, et al.
British Journal of Cancer
|
July 17, 1999
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
N Thatcher, E S De Campos, D R Bell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2002
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study
R Morant, S-F Hsu Schmitz, J Bernhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2000
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
A D Roth, R Maibach, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2015
Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial
N Fazio, R Biffi, R Maibach, et al.
Page
of 7